Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Archives of Razi Institute|November 26, 2021
Development and Evaluation of an Indirect Capripoxvirus ELISA Based on Truncated P32 Protein Expressed in E. coliM H Ebrahimi-Jam, H Keyvanfar, H R Varshovi, et al.
FEBS Letters|February 16, 2020
Viperin, through its radical-SAM activity, depletes cellular nucleotide pools and interferes with mitochondrial metabolism to inhibit viral replicationKourosh H Ebrahimi, Duncan Howie, Jack S Rowbotham, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 10, 2024
A Versatile Virus-Mimetic Engineering Approach for Concurrent Protein Nanocage Surface-Functionalization and Cargo EncapsulationYujie Sheng, Zilong Chen, Mickael V Cherrier, et al.
Frontiers in Immunology|January 2, 2023
Density dependent regulation of inflammatory responses in macrophagesAlun Vaughan-Jackson, Szymon Stodolak, Kourosh H Ebrahimi, et al.
Stem Cell Reports|June 25, 2021
Differentiation of human induced pluripotent stem cells to authentic macrophages using a defined, serum-free, open-source mediumAlun Vaughan-Jackson, Szymon Stodolak, Kourosh H Ebrahimi, et al.
FEBS Letters|January 6, 2025
The [2Fe-2S] cluster of mitochondrial outer membrane protein mitoNEET has an O2-regulated nitric oxide access tunnelThao Nghi Hoang, Meritxell Wu-Lu, Alberto Collauto, et al.
ESMO Open|November 19, 2025
Outcomes of immune checkpoint inhibitor rechallenge in advanced urothelial carcinoma: results from a global real-world evidence studyB A Maiorano, A Cigliola, V Tateo, et al.
ESMO Open|May 2, 2025
Multicenter analysis of high-dose chemotherapy regimens for the treatment of patients with refractory or recurrent germ cell tumorsA Chehrazi-Raffle, M Zugman, H Ebrahimi, et al.
International Journal of Environmental Science and Technology : IJEST|February 8, 2021
Occupational exposure of health care personnel to SARS-CoV-2 particles in the intensive care unit of Tehran hospitalR Yarahmadi, F Bokharaei-Salim, S Soleimani-Alyar, et al.
Ebiomedicine|February 13, 2022
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and PharmacodynamicsTom M Quinn, Erin E Gaughan, Annya Bruce, et al.
Pageof 3